Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia. The modernization will enable the company to expand its ...

(Reuters) -Consumer healthcare firm Haleon said on Monday that U.S. drugmaker Pfizer will sell down its stake in the company to about 24%. Pfizer, which currently holds a 32% stake in Haleon, said ...

A GSK spinoff that has its U.S. headquarters in Warren, Haleon boasts several well-known brands, including anti-inflammatory drug Advil, Centrum multivitamin, Sensodyne toothpaste, Theraflu cold & flu ...

Haleon earns distinction in the Family of Brands category for building enduring trust and consumer connection Award highlights Haleon’s leadership in purposeful innovation and consumer impact Haleon, ...